HARROW, INC. HROW
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2013-02-08
HARROW, INC. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Graves Adrienne L | director | 2026-05-18 | Buy | 1,000 | $31.07 |
| SILVERNAIL LAUREN P | director | 2026-05-18 | Buy | 1,000 | $31.00 |
| BAUM MARK L | CHIEF EXECUTIVE OFFICER | 2026-05-14 | Buy | 10,000 | $30.20 |
| BOLL ANDREW R. | PRESIDENT AND CFO | 2026-05-14 | Buy | 3,500 | $29.90 |
| Opaleye Management Inc. | 10% owner | 2026-03-04 | Sell | 134,000 | $39.67 |
| Opaleye Management Inc. | 10% owner | 2026-03-04 | Sell | 4,263 | $39.67 |
| Opaleye Management Inc. | 10% owner | 2026-03-03 | Sell | 59,000 | $39.15 |
| Opaleye Management Inc. | 10% owner | 2026-03-03 | Sell | 1,309 | $39.15 |
Source: SEC EDGAR filings · CIK 0001360214 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.